Melissa Eastgate

Royal Brisbane and Women's Hospital

Papers

1

Total Citations

2

H-Index

1

About

Melissa Eastgate is a health economist whose research focuses on the cost-effectiveness of minimally invasive cancer treatments, particularly within urological oncology. Her most-cited work presents a pivotal cost-effectiveness analysis comparing microwave ablation (MWA) to robot-assisted partial nephrectomy for patients with small renal masses in Australia. This study directly addresses a critical gap in the Australian healthcare landscape, providing evidence that MWA is a safe, minimally invasive, and economically viable alternative to surgery. By quantifying the relative value of these treatments, Eastgate’s research equips clinicians and policymakers with the data needed to optimize resource allocation and patient outcomes. Her work is foundational for integrating emerging technologies into public health systems, demonstrating a clear commitment to bridging clinical innovation with economic sustainability. Though early in her career, Eastgate’s contributions are already shaping the conversation around value-based cancer care, making her a rising voice in health technology assessment and evidence-based medicine.

Research Focus

Key Achievements

1
H-Index
1
Papers
2
Total Citations
2
Avg Citations/Paper
🏆 Most Cited Paper
Cost-effectiveness analysis of microwave ablation versus robot-assisted partial nephrectomy for patients with small renal masses in Australia
2 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 8
🏛 Institutions: Royal Brisbane and Women's Hospital

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago